Ongoing Clinical Trials Related to Arthroscopy
There is currently 1 clinical trial investigating approaches to improve outcomes for patients undergoing arthroscopic procedures. This trial is focused on pain management following shoulder surgery and is being conducted in France.
Clinical trial locations
Study on Pain Relief After Shoulder Surgery Using Tranexamic Acid and Sodium Chloride for Patients Undergoing Arthroscopic Procedures
This trial is focused on improving pain management for patients who undergo arthroscopic shoulder surgery. The study investigates whether tranexamic acid, a medication typically used to reduce bleeding, can also help decrease pain after surgery and reduce the need for strong pain relief medications.
Main inclusion criteria: To participate in this study, you must be at least 18 years old and scheduled to undergo shoulder arthroscopy. You must also be affiliated with a social security scheme and willing to sign an informed consent form after being fully informed about the study.
Main exclusion criteria: Patients who do not require shoulder arthroscopy, those outside the specified age range, or individuals considered part of a vulnerable population cannot participate in this trial.
Focus and goal: The primary goal of this trial is to evaluate whether tranexamic acid can reduce the amount of morphine needed for pain relief in the first 24 hours following shoulder surgery. During the procedure, some patients will receive tranexamic acid through an intravenous injection, while others will receive sodium chloride, a standard medical fluid, for comparison purposes. Researchers will assess shoulder pain at various time points after surgery using a visual scale, evaluate patient satisfaction with their anesthesia experience, and measure shoulder functionality 30 days after the procedure. The study will also monitor any side effects that occur throughout the trial period.
Investigational drugs: The trial uses tranexamic acid, administered intravenously during surgery. This medication works by preventing the breakdown of blood clots and is being studied for its potential to reduce post-operative pain. Morphine is also evaluated in the study as the standard pain relief medication used after surgery, with researchers measuring how much is needed when tranexamic acid is given compared to the standard treatment.
Summary
Currently, only one clinical trial related to arthroscopic procedures is actively recruiting patients. This trial is being conducted in France and focuses specifically on pain management following shoulder surgery. The study explores an innovative use of tranexamic acid, a medication traditionally used to control bleeding, to determine whether it can also help reduce post-operative pain and decrease the reliance on morphine for pain relief. This research could potentially lead to improved pain management strategies for patients undergoing arthroscopic shoulder procedures in the future.
